SLC2A9 and gout: For the ABCG2 variant a higher risk in men was observed compared with women (OR for gout in men 2.38 (95% CI 2.26–2.51), P = 3.72 × 10−235, and in women 1.63 (1.36–1.96), P = 1.19 × 10−7), whilst for the SLC2A9 variant the risk was not statistically different between sexes as demonstrated by overlapping 95% CIs (OR for gout in men 3.06 (95% CI 2.57–3.65), P = 6.71 × 10−36, and in women 4.13 (2.05–8.32), P = 7.06 × 10−5, Fig. 1).